Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Non Operating Income (2023 - 2025)

Historic Non Operating Income for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $4.1 million.

  • Upstream Bio's Non Operating Income rose 4084.8% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.3 million, marking a year-over-year increase of 4771.79%. This contributed to the annual value of $15.0 million for FY2024, which is 2359.4% down from last year.
  • Upstream Bio's Non Operating Income amounted to $4.1 million in Q3 2025, which was up 4084.8% from $4.4 million recorded in Q2 2025.
  • Over the past 5 years, Upstream Bio's Non Operating Income peaked at $6.3 million during Q3 2023, and registered a low of $2.5 million during Q4 2023.
  • Over the past 3 years, Upstream Bio's median Non Operating Income value was $4.1 million (recorded in 2024), while the average stood at $4.1 million.
  • Examining YoY changes over the last 5 years, Upstream Bio's Non Operating Income showed a top increase of 10328.39% in 2024 and a maximum decrease of 5383.51% in 2024.
  • Upstream Bio's Non Operating Income (Quarter) stood at $2.5 million in 2023, then soared by 103.28% to $5.1 million in 2024, then decreased by 19.5% to $4.1 million in 2025.
  • Its Non Operating Income was $4.1 million in Q3 2025, compared to $4.4 million in Q2 2025 and $4.7 million in Q1 2025.